Diabetes Mellitus, Insulin-Dependent
GPTKB entity
Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
|
| gptkbp:abbreviation |
gptkb:IDDM
|
| gptkbp:affects |
adults
children pancreas endocrine system |
| gptkbp:alsoKnownAs |
gptkb:Type_1_Diabetes_Mellitus
|
| gptkbp:associatedWith |
gptkb:HLA-DR4
autoantibodies HLA-DR3 |
| gptkbp:canBeComplicatedBy |
gptkb:cardiovascular_disease
stroke peripheral vascular disease |
| gptkbp:cannotBeTreatedWith |
oral hypoglycemic agents
|
| gptkbp:cause |
gptkb:hypoglycemia
hyperglycemia |
| gptkbp:causedBy |
obesity
lifestyle factors autoimmune destruction of pancreatic beta cells |
| gptkbp:complication |
gptkb:diabetic_ketoacidosis
gptkb:nephropathy peripheral neuropathy retinopathy |
| gptkbp:diagnosedBy |
HbA1c test
fasting blood glucose |
| gptkbp:firstDescribed |
19th century
|
| gptkbp:hasBiomarker |
GAD antibodies
C-peptide (low or absent) islet cell antibodies |
| https://www.w3.org/2000/01/rdf-schema#label |
Diabetes Mellitus, Insulin-Dependent
|
| gptkbp:ICD-10_code |
E10
|
| gptkbp:managedBy |
physical activity
dietary management blood glucose monitoring |
| gptkbp:onset |
childhood
adolescence |
| gptkbp:prevalence |
less common than Type 2 Diabetes
|
| gptkbp:primaryTreatment |
insulin therapy
|
| gptkbp:requires |
lifelong management
|
| gptkbp:riskFactor |
family history
genetic predisposition |
| gptkbp:subspecies |
Juvenile Diabetes
Latent Autoimmune Diabetes in Adults |
| gptkbp:symptom |
weight loss
polydipsia polyuria polyphagia |
| gptkbp:bfsParent |
gptkb:D004053
gptkb:D004481 |
| gptkbp:bfsLayer |
7
|